je.st
news
Market Volatility Leaves Behind Bargain Cancer Biotech - Adaptimmune
2015-09-10 20:44:16| Biotech - Topix.net
Adaptimmune just hit its all-time low on the NASDAQ after closing just above $11 per share. Since offering shares in early May, the company has traded largely in the $14.50-$15.50 price range.
Tags: market
cancer
leaves
bargain
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||